Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy
Clinical trial NCT03719690 · COMPLETED
Trial details
- NCT number
- NCT03719690
- Sponsor
- Kura Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-15
- Primary completion
- 2023-05-02
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.